STUDY OF EXPIRED AIR CONDENSATE IN PEDIATRIC RESPIRATORY DISEASES: REALITY AND PERSPECTIVES*

Abstract


The data on the possibility of using the expired air condensate study in respiratory diseases are presented in the paper. The expired air condensate can consist of both volatile compound and heavy low-volatile substances (lipids, inflammatory mediators, cytokines, oxidants, hydrogen peroxide, nitrates and others). This method of non-invasive assessment of inflammatory respiratory changes in children is applied during scientific studies in case of bronchial asthma, mucoviscidosis, respiratory infections and some other diseases. The basic factors limiting clinical use of expired air condensate analysis in children are the level variability and low biomarker concentrations (at the susceptibility threshold of the existing methods of analysis).

About the authors

E G Furman

Email: furman1@yandex.ru

Yu M Pechenkin

References

  1. Анаев Э. Х., Чучалин А. Г. Исследование конденсата выдыхаемого воздуха в пульмонологии (обзор зарубежной литературы). Пульмонология 2002; 2: 57-65.
  2. Климанов И. А., Соодаева С. К., Лисица А. В., Кудрявцев В. Б., Чучалин А. Г. Стандартизация преаналитического этапа исследования конденсата выдыхаемого воздуха. Пульмонология 2006; 2: 53-55.
  3. Ларюшкина Р. М., Рывкин А. И., Побединская Н. С., Решетова Т. Г., Соколова Т. Б., Филина И. В. Изменения фосфолипидных компонентов легочного сурфактанкта и их коррекция при атопической бронхиальной астме. Педиатрия 2010; 89 (4): 17-21.
  4. Сидоренко Г. И., Зборовский Э. И., Левина Д. И. Поверхностно-активные свойства конденсата выдыхаемого воздуха (новый способ исследования функций легких). Терапевтический архив 1980; 3: 65-68.
  5. Фурман Е. Г., Корюкина И. П. Бронхиальная астма у детей: маркеры воспаления и состояние функции внешнего дыхания. Пермь 2010; 183.
  6. Bodini A., D'Orazio C., Peroni D., Corradi M., Folesani G., Baraldi E., Assael B. M., Boner A., Piacentini G. L. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr. Pulmonol. 2005; 40 (6): 494-499.
  7. Carpagnano G. E., Palladino G. P., Gramiccioni C., Foschino Barbaro M. P., Martinelli D. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients. Lung. Cancer 2010; 68; 305-307.
  8. Dut R., Dizdar E. A., Birben E., Sackesen C., Soyer O. U., Besler T., Kalayci O. Oxidative stress and its determinants in the airways of children with asthma. Allergy 2008; 63 (12): 1605-1609.
  9. Exhaled Biomarkers / edited by I. Horvath. European Respiratory Society Monograph 2010; 49: 198.
  10. Kazani S., Israel E. Exhaled breath condensates in asthma: diagnostic and therapeutic implications. J. Breath. Res. 2010; 4: 1512-1521.
  11. Kharitonov S. A., Barnes P. J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002; 7 (1): 1-32.
  12. Klimanov I. A., Soodaeva S. K. Mechanisms of production of exhaled breath condensate and oxidative markers in respiratory diseases. Pulmonology 2009; 2: 113-119.
  13. Lex C., Zacharasiewicz A., Payne D. N. R., Wilson N. M., Nicholson A. G., Kharitonov S. A., Barnes P. J., Bush A. Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: A pilot study. Respir. Res. 2006; 7: 63-71.
  14. MacGregor G., Ellis S., Andrews J., Imrie M., Innes A., Greening A. P., Cunningham S. Breath condensate ammonium is lower in children with chronic asthma. Eur. Respir. J. 2005; 26 (2): 271-276.
  15. Montuschi P. LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2009; 877 (13): 1272-1280.
  16. Nicolaou, N. C., Lowe, L. A., Murray, C. S., Woodcock, A., Simpson, A., Custovic, A. Exhaled breath condensate pH and childhood asthma: Unselected birth cohort study. Am. J. Respir. Crit. Care. Med. 2006; 174 (3): 254-259.
  17. Profita M., La Grutta S., Carpagnano E., Riccobono L., Di Giorgi R., Bonanno A., Pace E., Gjomarkaj M. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J. Allergy Clin. Immunol. 2006; 118 (5): 1068-1074.
  18. Ratnawati Morton J., Henry R. L., Thomas P. S. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol. 2006; 41 (10): 929-936.
  19. Robroeks C. M. H. H. T., Jöbsis Q., Damoiseaux J. G. M. C., Heijmans P. H. M., Rosias P. P. R., Hendriks H. J. E., Dompeling E. Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann. Allergy Asthma Immunol. 2006; 96 (2): 349-355.
  20. Shibata A., Katsunuma T., Tomikawa M., Tan A., Juki K., Akashi K., Eto J. Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 2006; 130 (6): 1718-1722.
  21. Thomas P. S., Lowe A. J., Samarasinghe P., Lodge C. J., Huang Y., Abramson M. J., Dharmage S. C., Jaffe A. Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? A Systematic Review. Pediatr Pulmonol. 2013; 48: 419-442.

Statistics

Views

Abstract - 372

PDF (Russian) - 243

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Comments on this article

Comments on this article

View all comments

Copyright (c) 2014 Furman E.G., Pechenkin Y.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies